An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
1 Division of Immunology, Boston Children's Hospital, Boston, MA, United States of America.
2 Division of Immunology, Boston Children's Hospital, Boston, MA, United States of America. Electronic address: Douglas.McDonald@childrens.harvard.edu.
1 Division of Immunology, Boston Children's Hospital, Boston, MA, United States of America.
2 Division of Immunology, Boston Children's Hospital, Boston, MA, United States of America. Electronic address: Douglas.McDonald@childrens.harvard.edu.
The COVID-19 pandemic is one of the greatest infectious challenges in recent history. Presently, few treatment options exist and the availability of effective vaccines is at least one year away. There is an urgent need to find currently available, effective therapies in the treatment of patients with COVID-19 infection. In this review, we compare and contrast the use of intravenous immunoglobulin and hyperimmune globulin in the treatment of COVID-19 infection.
Declaration of Competing Interest The authors declare no conflicts of interest.
Figures
Fig. 1
Proposed mechanisms of neutralizing antibodies…
Fig. 1
Proposed mechanisms of neutralizing antibodies and IVIG in COVID-19 infection. (a) Neutralizing antibodies…
Fig. 1
Proposed mechanisms of neutralizing antibodies and IVIG in COVID-19 infection. (a) Neutralizing antibodies prevent SARS-CoV2 spike protein from attaching to the ACE2 receptor, inhibiting viral entry into the cell. (b) Immune complexes consisting of viral antigens and anti-viral sub-neutralizing antibodies can activate Fcγ receptors on innate immune cells (e.g. macrophages) in the lung, triggering an exaggerated inflammatory response leading to acute lung injury via antibody dependent enhancement (ADE). Additionally, antibody-bound virus can be internalized through Fcγ receptors, enhancing viral replication. (c) Proposed mechanisms whereby IVIG exerts anti-inflammatory action include saturation of Fcγ receptor binding, anti-idiotypic binding to anti-viral antibodies, and binding of proinflammatory cytokines.
Walls A.C., Park Y.J., Tortorici M.A., Wall A., McGuire A.T., Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181(2):281–292. (e6)
-
PMC
-
PubMed
ter Meulen J., van den Brink E.N., Poon L.L., Marissen W.E., Leung C.S., Cox F. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants. PLoS Med. 2006;3(7)
-
PMC
-
PubMed
Prompetchara E., Ketloy C., Palaga T. Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pac. J. Allergy Immunol. 2020;38(1):1–9.
-
PubMed
Choe P.G., Perera R., Park W.B., Song K.H., Bang J.H., Kim E.S. MERS-CoV antibody responses 1 year after symptom onset, South Korea, 2015. Emerg. Infect. Dis. 2017;23(7):1079–1084.
-
PMC
-
PubMed
To KK, Tsang O.T., Leung W.S., Tam A.R., Wu T.C., Lung D.C. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect. Dis. 2020;20(5):565–574.
-
PMC
-
PubMed